Results 221 to 230 of about 60,875 (277)

Reduced Sperm Counts in Mice with <i>Dmd</i> Exon 51 Frameshift Mutations. [PDF]

open access: yesGenes (Basel)
Ilchuk LA   +7 more
europepmc   +1 more source

Feedback Protocols for Dissipation Control in Small Systems

open access: yesAnnalen der Physik, Volume 538, Issue 11, November 2026.
Single‐molecule pulling experiments recover folding free energies from irreversible work, but dissipation biases the result. Comparing feedback protocols on a model DNA hairpin at equal measurement time, the authors show that reduced dissipation does not always improve free‐energy estimates.
S. Peyriere, F. Ritort
wiley   +1 more source

Student‐identified barriers to histology learning and the perceived value of coloring as a multimodal educational strategy

open access: yesAnatomical Sciences Education, Volume 19, Issue 11, Page 2028-2037, November 2026.
Abstract Histology is a visually complex and cognitively demanding subject often perceived as abstract, memorization‐heavy, and disconnected from clinical practice. Despite its foundational importance, histology is frequently under‐emphasized relative to gross anatomy and lacks interactive, multimodal resources tailored to its unique challenges.
Anika Knowles   +2 more
wiley   +1 more source

Influence of community disadvantage on cognitive performance in son-mother dyads in Duchenne muscular dystrophy. [PDF]

open access: yesBrain Commun
Karra H   +7 more
europepmc   +1 more source

Nucleic Acid Therapeutics in Rare Disease: From Precision Medicine to Programmable Platforms

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 6, November 2026.
ABSTRACT Nucleic acid therapeutics (NATs), including antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), messenger RNA (mRNA) therapeutics and programmable editing technologies, are reshaping the therapeutic landscape for inherited metabolic and genetic disease.
Tomasz Z. Tomkiewicz   +3 more
wiley   +1 more source

Clinical History and Burden of Gaucher Disease Type 3: A Cross‐Sectional Multinational Study

open access: yesJIMD Reports, Volume 67, Issue 6, November 2026.
ABSTRACT Gaucher disease Type 3 (GD3) is a rare genetic neurodegenerative disorder, characterized by heterogeneity in symptom burden, disease severity, and progression. There is limited evidence on the burden of GD3. This retrospective, cross‐sectional study estimated the burden of illness associated with GD3 using descriptive analyses of clinician ...
Eugen Mengel   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy